New York State Common Retirement Fund
VIGL

New York State Common Retirement Fund’s Vigil Neuroscience VIGL Stock Holding History

New York State Common Retirement Fund’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-140
Closed -$560 – 3344
2024
Q2 		$560 Sell
140
-10,000
-99% -$34.2K ﹤0.01% 3328
2024
Q1 		$34.6K Hold
10,140
– – ﹤0.01% 3071
2023
Q4 		$34.3K Sell
10,140
-25
-0.2% -$129 ﹤0.01% 3080
2023
Q3 		$54.8K Buy
10,165
+165
+2% +$1.14K ﹤0.01% 2994
2023
Q2 		$94K Buy
+10,000
New +$94.5K ﹤0.01% 2906
2022
Q3 		– Sell
-59
Closed – – 3454
2022
Q2 		$0 Sell
59
-8,441
-99% -$33.3K ﹤0.01% 3543
2022
Q1 		$60K Buy
+8,500
New +$112K ﹤0.01% 3133

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund's VIGL Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Vigil Neuroscience (VIGL) in Q3 2024, closing a stake of 140 shares — an estimated $560 sold.

New York State Common Retirement Fund first reported a position in VIGL in Q1 2022 and held it in 7 quarters. The position peaked at $94K in Q2 2023. 52 funds tracked by Wall St. Rank hold VIGL as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Vigil Neuroscience position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 140 Vigil Neuroscience shares in Q3 2024, an estimated $560.
  • New York State Common Retirement Fund first reported a position in Vigil Neuroscience in Q1 2022 and held it in 7 quarters.
  • New York State Common Retirement Fund's Vigil Neuroscience position peaked at $94K in Q2 2023.
  • 52 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.